ICON plc has made senior appointments to its clinical research, medical imaging and commercialization and outcomes services. Dr. Andrew Garrett has been appointed executive vice president, Scientific Operations, Dr. Paul McCracken was named vice president, Medical Imaging, and Jim Carroll has been appointed vice president, Real World Evidence (RWE).
 
Dr. Andrew Garrett has more than 30 years of experience within the pharmaceutical and CRO industries. At ICON, Dr. Garrett has global responsibility for the strategic vision and operational execution of  scientific operations, including biostatistics and programming, pharmacovigilance, regulatory and medical affairs, medical writing, medical imaging and interactive technologies. Dr. Garrett joins the company from Quintiles, where he led the global clinical analysis and reporting services group.
 
Dr. Paul McCracken brings more than 20 years of experience in imaging and pharmaceuticals, as well as applying imaging and biomarkers to drug discovery and development across a range of therapeutic areas. Dr. McCracken joins the company from Eisai, where he led the Imaging Centre of Excellence.
 
Jim Carroll will lead the RWE Center of Excellence, which develops real world data (RWD) and technology based solutions to support sponsors who are seeking to expand labelling and market access, as well as the growing demand for evidenced-based requirements. Jim has more than 20 years of CRO and pharmaceutical experience. He joins the company from inVentiv Health, where he led the formation of a new business unit focused on providing novel RWD-driven services.
 
Dr. Steve Cutler, ICON’s chief operating officer, said: “I’m delighted to welcome Andrew, Paul and Jim to the ICON team. They bring a wealth of scientific operational, and commercialization expertise to ICON which will help us to advance our clients’ products through their development pipelines and also drive their commercial success.”